Sign in
Taking people in United StatesNo phase

Inflammation genes and childhood trauma in people with hidradenitis suppurativa

Compares inflammation signals in people with hidradenitis suppurativa and controls, plus childhood trauma effects.

Key facts

Who runs it
University of Alabama at Birmingham
Where
Birmingham, United StatesSee the site
Trial code
Registry title
Regulation of Inflammatory Genes in Hidradenitis Suppurativa
Status
Recruiting
People taking part
200 people, planned
Started
11 Oct 2022
Expected to end
31 Aug 2028
Type of study
Observational, 2 groups
Treatments tested
  • Mental health
Record updated
21 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with hidradenitis suppurativa (HS), a long-lasting skin disease with painful lumps, and for control people without inflammatory skin disease. It studies inflammation genes in the blood and skin. An optional extra study looks at how childhood trauma affects HS.

Age
18 Years to 89 Years
Sex
All sexes
Disease stage
People in the HS group must have a diagnosis of hidradenitis suppurativa. People in the control group must not have an inflammatory skin disease.

Main reasons for not taking part

  • Being pregnant
  • Control group: having HS, psoriasis, rosacea, atopic dermatitis or another inflammatory skin disease
  • Mild or general skin issues such as moles or other cosmetic problems

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Diagnosed with hidradenitis suppurativa
  • Not Pregnant

Who cannot take part

  • Patients with hidradenitis suppurativa, psoriasis, roasacea, atopic dermatitis and other inflammatory skin disease
  • Mild/general dermatological issues like moles, other cosmetic issues
  • Pregnant

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 89 years old?

Where in United States

  • Whitaker ClinicBirmingham, United StatesContact: Nabiha YusufTaking people

About the trial

What the trial wants to find out

The purpose of this protocol is to examine the cytokine profi le of pati ents with hidradeniti s suppurati va (HS) and idemechanisms responsible for post-transcripti onal regulati on of these genes. The primary objecti ve is to determinfollowing cytokines linked to hidradeniti s suppurati va are diff erenti ally expressed in hidradeniti s pati ents versus controlalso doing a sub-study to determine the eff ect of childhood trauma on HS. The parti cipati on in the sub-study is opti onal

The 2 groups in the trial

  • Control

    Participants without inflammatory skin disease

    Treatment: Mental health

  • Patients with HS

    Treatment: Mental health

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Regulation of Inflammatory Genes in Hidradenitis Suppurativa
Plain-language title
Inflammation genes and childhood trauma in people with hidradenitis suppurativaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05507125, who can take part
Record updated
21 September 2026